RxDoctor Payments Data

Gregory Bailey, DO

Orthopaedic Surgery of the Spine · State College, PANPI 1639245210

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $831,377 of the $1,056,342 with a category attached, or 78.7%. 24 manufacturers reported payments, led by The Institute Of Musculoskeletal Science And Education at 41.4% of the total. Among orthopaedic surgery of the spine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$1,056,342in general payments, 2019–2025

Across 204 payments — averaging $5178.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • The Institute Of Musculoskeletal Science And Education$438K
  • Philadelphia Medical Management Company LLC$189K
  • Camber Spine Technologies LLC$152K
  • Medtronic$132K
  • Globus Medical$86K
  • Medicrea USA, Corp.$34K
  • plus $26K from 18 others
$21,626in research payments, 2019–2025

Across 6 payments — averaging $3604.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Ossdsign USA Incorporated$22K

What the payments were for

  • Royalty or licence$831,37779%
  • Consulting fees$110,58610%
  • Speaking & faculty fees$97,0629%
  • Travel & lodging$10,3071%
  • Food & beverage$7,0111%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,056,342 in reported general payments places this provider in the 95th percentile of 43 orthopaedic surgery of the spine providers in Pennsylvania.

See all orthopaedic surgery of the spine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$528,283
Medicare patients
676
Services billed
2,252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone Hcl198$1,006
Tramadol Hcl171$480
Gabapentin26$256
Methylprednisolone34$254
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen24$178
Cyclobenzaprine Hcl18$70

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in State College

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →